| Ytd | -57.72% | |
| 1y | -49.33% |
| Open | 8.61 | Prev Close | 8.70 | Low | 8.30 | High | 8.78 | Mkt Cap | 1.73B |
| Vol | 23.59M | Avg Vol | 6.06M | EPS | 0.19 | P/E | 43.95 | Forward P/E | 11.10 |
| Beta | 1.11 | Short Ratio | 3.97 | Inst. Own | 115.94% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-29 | 50-d Avg | 15.34 | 200-d Avg | 18.64 | 1yr Est | 22.23 |
LOS ANGELES, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP, a leading nationa
BENSALEM, Pa., Sept. 17, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G.
SAN FRANCISCO, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Hagens Berman is updating its ongoing investigatio
LOS ANGELES, Sept. 16, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its inves
Alignment Healthcare, Inc. (NASDAQ: ALHC - Get Free Report) shares reached a new 52-week low during
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an inve
NEW YORK, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP is investigating potential
Alignment Healthcare, Inc. (NASDAQ: ALHC - Get Free Report) CEO John Kao sold 385,270 shares of the
Key indicators worsened in 2026, including aging in place challenges, support gaps, and medical debt
New York, New York--(Newsfile Corp. - September 9, 2026) - Kaplan Fox & Kilsheimer LLP is investigat
NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP is investigating potential
New York, New York--(Newsfile Corp. - September 8, 2026) - Kaplan Fox & Kilsheimer LLP is investigat
Expanded provider relationship increases access to Hoag physicians, hospitals and specialty programs
New York, New York--(Newsfile Corp. - September 4, 2026) - Kaplan Fox & Kilsheimer LLP is investigat
NEW YORK, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP is investigating potential
Jupiter Topco LLC bought a new stake in Alignment Healthcare, Inc. (NASDAQ: ALHC) during the second
New York, New York--(Newsfile Corp. - September 3, 2026) - Kaplan Fox & Kilsheimer LLP is investigat
New York, New York--(Newsfile Corp. - September 2, 2026) - Kaplan Fox & Kilsheimer LLP is investigat
NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP is investigating potential
New York, New York--(Newsfile Corp. - September 1, 2026) - Kaplan Fox & Kilsheimer LLP is investigat
U.S. stocks mixed, Nasdaq up 0.1%. Abercrombie & Fitch shares surge 31.6% after beating earnings
JP Morgan analyst John Stansel maintains Alignment Healthcare (NASDAQ:ALHC) with a Overweight and
Raymond James analyst John Ransom downgrades Alignment Healthcare (NASDAQ:ALHC) from Strong Buy t
Gainers Scribe Therapeutics (NASDAQ:SCTX) shares increased by 12.7% to $23.0 during Thursday's
Alignment Healthcare (NASDAQ:ALHC) raises FY2026 sales outlook from $5.160 billion-$5.205 billion to
Alignment Healthcare (NASDAQ:ALHC) sees Q3 sales of $1.300 billion-$1.320 billion vs $1.315 billion
Alignment Healthcare (NASDAQ:ALHC) reported quarterly earnings of $0.17 per share which beat the ana
https://www.spglobal.com/spdji/en/documents/indexnews/announcements/20260511-1483319/1483319_sncy-60
UBS analyst Jonathan Yong maintains Alignment Healthcare (NASDAQ:ALHC) with a Neutral and raises
Barclays analyst Andrew Mok maintains Alignment Healthcare (NASDAQ:ALHC) with a Equal-Weight and
Alignment Healthcare (NASDAQ:ALHC) sees Q2 sales of $1.295 billion-$1.315 billion vs $1.315 billion
Alignment Healthcare (NASDAQ:ALHC) raises FY2026 sales outlook from $5.135 billion-$5.190 billion to
Alignment Healthcare (NASDAQ:ALHC) reported quarterly earnings of $0.05 per share which beat the ana
US stocks traded lower, Nasdaq fell 1% on Tuesday. Energy sector up 1.7%, consumer discretionary dow
Medicare Advantage stocks surge as CMS finalizes 2027 rates. Read about the 2.48% base rate hike and
Dow Jones falls 250 points as UnitedHealth Group rises on Medicare reimbursement boost, other stocks
SILO stock rose 51.8% in pre-market trading after its PTSD treatment pipeline received a patent from
https://www.cms.gov/newsroom/press-releases/cms-finalizes-2027-medicare-advantage-part-d-payment-pol
Astrana Health shares fell 22% after CMS proposed modest Medicare Advantage growth, but analyst says
https://www.politico.com/newsletters/inside-congress/2025/11/24/trumps-obamacare-move-blindsides-con